SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: AlienTech who wrote (13494)8/17/1998 12:23:00 PM
From: VLAD  Read Replies (5) | Respond to of 23519
 
alien,

Also keep in mind that the imitation probably will not be of good quality. Add to this the outright fake Viagra and we see a high failure rate. Then when Viagra is formally released those already failing on the junk will believe that the stuff doesn't work and will not even bother going to the doc for the legal stuff. Good for Vivus and bad for Pfizer.



To: AlienTech who wrote (13494)8/17/1998 12:28:00 PM
From: Mkilloran  Respond to of 23519
 
alien...Viagra and the India clone will battle it out in some markets. Yes the clone will be cheaper.

But Muse will be available to the sub-set of ED patients that should not use Viagra or India's clone.

As soon as Muse is in Hong Kong ...it will start to show up in the black market in mainland China.



HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News